A carregar...

Oligoclonal Antibodies to Target the ErbB Family

INTRODUCTION: Use of monoclonal antibodies to inhibit signaling through the ErbB receptor tyrosine kinase family has proven to be an effective strategy for treating ErbB-driven cancers. Advances in the field of antibody engineering and manufacturing now allow us to more effectively mimic the natural...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Expert Opin Biol Ther
Main Authors: D'Souza, Jimson W., Robinson, Matthew K.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4480362/
https://ncbi.nlm.nih.gov/pubmed/25936923
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14712598.2015.1042362
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!